Health
Obesity Drugs Show Promise Against Hormonal Disorder PMOS
GLP-1 obesity drugs show early promise treating PMOS, a hormonal disorder affecting 170 million women, but insurance barriers remain.
—4 min read
Tag
3 articles
GLP-1 obesity drugs show early promise treating PMOS, a hormonal disorder affecting 170 million women, but insurance barriers remain.
New CM study reveals growing health inequality in Belgium: lower-income citizens face worse health and spend more on care.
Four-year-old Kasper needs €315,000 CAR-T therapy in Rome, not reimbursed in Belgium. His family's crowdfunding highlights gaps in cancer care.